Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Description Retatrutide is an advanced triple-agonist peptide developed by Eli Lilly that simultaneously activates the GLP-1, GIP, and glucagon receptors
Krumlovsky FA, Del Greco F, Herdson PB, Lazar P
Real manufacturer with our own factory located in China 3
Webb et al
Most commercial insurance plans that cover GLP-1 for weight loss require prior authorization documenting: BMI at or above 30 (or 27 with a weight-related condition like hypertension, type 2 diabetes, dyslipidemia, or sleep apnea), and in some cases, documented prior attempts at lifestyle modification
US$ 20.92
US$ 22.06
US$ 22.55
US$ 27.54
